Recent interest in the
annexin 1 field has come from the notion that specific
G-protein-coupled receptors, members of the
formyl-peptide receptor (FPR) family, appear to mediate the anti-inflammatory actions of this endogenous mediator. Administration of the
annexin 1 N-terminal derived
peptide Ac2-26 to mice after 25 min
ischemia significantly attenuated the extent of acute myocardial injury as assessed 60 min postreperfusion. Evident at the dose of 1 mg/kg (approximately 9 nmol per animal),
peptide Ac2-26 cardioprotection was intact in FPR null mice. Similarly,
peptide Ac2-26 inhibition of specific markers of
heart injury (specifically
myeloperoxidase activity,
CXC chemokine KC contents, and endogenous
annexin 1
protein expression) was virtually identical in heart samples collected from wild-type and FPR null mice. Mouse myocardium expressed the
mRNA for FPR and the structurally related
lipoxin A4 receptor, termed ALX; thus, comparable equimolar doses of two ALX agonists (W
peptide and a stable
lipoxin A4 analog) exerted cardioprotection in wild-type and FPR null mice to an equal extent. Curiously, marked (>95%) blood
neutropenia produced by an anti-mouse neutrophil serum did not modify the extent of acute
heart injury, whereas it prevented the protection afforded by
peptide Ac2-26. Thus, this study sheds light on the receptor mechanism(s) mediating
annexin 1-induced cardioprotection and shows a pivotal role for ALX and circulating neutrophil, whereas it excludes any functional involvement of mouse FPR. These mechanistic data can help in developing novel
therapeutics for acute cardioprotection.